• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由该基因突变引起的家族性间质性肺疾病。

Familial Interstitial Lung Disease Caused by Mutation of the Gene.

作者信息

Li Jinying, An Shuhua, Du Zhongdong

机构信息

Department of Pediatrics, Beijing Children's Hospital, Capital Medical University, Beijing, China.

Department of Respiratory, Children's Hospital of Hebei Province, Shijiazhuang, China.

出版信息

Front Pediatr. 2020 Sep 8;8:543. doi: 10.3389/fped.2020.00543. eCollection 2020.

DOI:10.3389/fped.2020.00543
PMID:33014937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7505928/
Abstract

Mutations that affect the (TMEM173) gene cause a rare autoinflammatory syndrome, which is known as STING-associated vasculopathy with onset in infancy (SAVI) and which was initially described in 2014 (1). Thus far, only four reports have been conducted regarding families affected with SAVI in the literature. In this article, the clinical, laboratory, and genetic characteristics of two generations (three cases) of SAVI are described. Unlike previously reported cases that were caused by mutation, the initial and major clinical manifestations of the mentioned cases are largely identified in the lungs with interstitial lung disease (ILD), and the evidence of typical extrapulmonary symptoms of early-onset systemic inflammation (e.g., cutaneous vasculopathy) were minimal except for the proband, who was diagnosed with arthritis 8 years after onset. In addition, a younger sibling showed no symptoms. Such reports are rarely related to mutations in . The proband was examined with bronchoscopy and alveolar lavage to determine the cause. This study emphasizes that, in the clinical assessment of interstitial pneumonia in children, the possibility of mutation should be considered, especially in patients with arthritis in addition.

摘要

影响(TMEM173)基因的突变会导致一种罕见的自身炎症综合征,即婴儿期起病的STING相关血管病(SAVI),该病于2014年首次被描述(1)。迄今为止,文献中仅有四篇关于SAVI患者家系的报道。本文描述了两代(三例)SAVI患者的临床、实验室及遗传学特征。与之前报道的由突变引起的病例不同,上述病例的初始及主要临床表现大多出现在肺部,表现为间质性肺疾病(ILD),除先证者在发病8年后被诊断为关节炎外,早期全身性炎症典型的肺外症状(如皮肤血管病)证据极少。此外,一名年幼的同胞未出现症状。此类报道很少与突变相关。对先证者进行了支气管镜检查及肺泡灌洗以明确病因。本研究强调,在儿童间质性肺炎的临床评估中,应考虑突变的可能性,尤其是同时患有关节炎的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/67a78cd38e8e/fped-08-00543-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/a536cc8e34fc/fped-08-00543-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/244730974b03/fped-08-00543-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/12dd7154a292/fped-08-00543-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/b56046f6d195/fped-08-00543-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/e7f681850965/fped-08-00543-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/3fc698e99b57/fped-08-00543-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/1a74cb6b2051/fped-08-00543-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/3c051b498618/fped-08-00543-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/67a78cd38e8e/fped-08-00543-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/a536cc8e34fc/fped-08-00543-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/244730974b03/fped-08-00543-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/12dd7154a292/fped-08-00543-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/b56046f6d195/fped-08-00543-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/e7f681850965/fped-08-00543-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/3fc698e99b57/fped-08-00543-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/1a74cb6b2051/fped-08-00543-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/3c051b498618/fped-08-00543-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb89/7505928/67a78cd38e8e/fped-08-00543-g0009.jpg

相似文献

1
Familial Interstitial Lung Disease Caused by Mutation of the Gene.由该基因突变引起的家族性间质性肺疾病。
Front Pediatr. 2020 Sep 8;8:543. doi: 10.3389/fped.2020.00543. eCollection 2020.
2
STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.婴儿期起病的STING相关性血管病:一项家族性病例系列报告及文献综述
Ann Transl Med. 2021 Jan;9(2):176. doi: 10.21037/atm-20-6198.
3
STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.婴儿期起病的STING相关血管病(SAVI)伴皮肤损害。
Pediatr Dermatol. 2024 Sep-Oct;41(5):893-896. doi: 10.1111/pde.15620. Epub 2024 Apr 29.
4
A case of STING-associated vasculopathy with onset in infancy with novel STING1 variant.婴儿期起病的 STING 相关性血管病伴新发性 STING1 变异病例报告。
Pediatr Dermatol. 2024 Jul-Aug;41(4):697-700. doi: 10.1111/pde.15559. Epub 2024 Feb 18.
5
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.21 例婴儿起病的 STING 相关性血管病(SAVI)概述。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):803-818.e11. doi: 10.1016/j.jaip.2020.11.007. Epub 2020 Nov 18.
6
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.隐性 STING 相关血管病伴婴儿期起病的表型谱:四例新病例及对既往报道病例的分析。
Front Immunol. 2022 Oct 6;13:1029423. doi: 10.3389/fimmu.2022.1029423. eCollection 2022.
7
Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.以间质性肺病为表现的 1 型干扰素病:一种新表型的报告。
Pediatr Rheumatol Online J. 2020 May 12;18(1):37. doi: 10.1186/s12969-020-00425-w.
8
Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.三位 SAVI 综合征患者在使用 Janus 激酶抑制剂的情况下进行肺移植。
J Clin Immunol. 2023 Nov;43(8):2156-2164. doi: 10.1007/s10875-023-01595-4. Epub 2023 Oct 10.
9
STING-Mediated Lung Inflammation and Beyond.STING 介导的肺部炎症及其他作用
J Clin Immunol. 2021 Apr;41(3):501-514. doi: 10.1007/s10875-021-00974-z. Epub 2021 Feb 2.
10
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.病例报告:巴瑞替尼治疗婴儿期起病的 STING 相关性血管病中 JAK1/2 的抑制作用。
Pediatr Rheumatol Online J. 2023 Oct 26;21(1):131. doi: 10.1186/s12969-023-00916-6.

引用本文的文献

1
The pathogenesis, clinical presentations and treatment of monogenic systemic vasculitis.单基因系统性血管炎的发病机制、临床表现及治疗
Nat Rev Rheumatol. 2025 May 14. doi: 10.1038/s41584-025-01250-9.
2
Innovations in Childhood Interstitial and Diffuse Lung Disease.儿童间质性和弥漫性肺病的创新。
Clin Chest Med. 2024 Sep;45(3):695-715. doi: 10.1016/j.ccm.2024.04.002.
3
A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.婴儿期起病的 STING 相关性血管病的罕见表现:病例报告。

本文引用的文献

1
Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.以间质性肺病为表现的 1 型干扰素病:一种新表型的报告。
Pediatr Rheumatol Online J. 2020 May 12;18(1):37. doi: 10.1186/s12969-020-00425-w.
2
Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome.Janus 激酶抑制剂治疗 SAVI 综合征的疗效和不良事件。
J Clin Immunol. 2019 Jul;39(5):476-485. doi: 10.1007/s10875-019-00645-0. Epub 2019 May 29.
3
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Pediatr Rheumatol Online J. 2024 Jan 4;22(1):9. doi: 10.1186/s12969-023-00934-4.
4
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.病例报告:巴瑞替尼治疗婴儿期起病的 STING 相关性血管病中 JAK1/2 的抑制作用。
Pediatr Rheumatol Online J. 2023 Oct 26;21(1):131. doi: 10.1186/s12969-023-00916-6.
5
Analysis of mRNA-miRNA-lncRNA differential expression in prediabetes/type 2 diabetes mellitus patients as potential players in insulin resistance.分析糖尿病前期/2 型糖尿病患者中 mRNA-miRNA-lncRNA 的差异表达,作为胰岛素抵抗的潜在靶点。
Front Endocrinol (Lausanne). 2023 May 8;14:1131171. doi: 10.3389/fendo.2023.1131171. eCollection 2023.
6
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.隐性 STING 相关血管病伴婴儿期起病的表型谱:四例新病例及对既往报道病例的分析。
Front Immunol. 2022 Oct 6;13:1029423. doi: 10.3389/fimmu.2022.1029423. eCollection 2022.
7
Dysregulation of the cGAS-STING Pathway in Monogenic Autoinflammation and Lupus.cGAS-STING 通路在单基因自身炎症和狼疮中的失调。
Front Immunol. 2022 May 27;13:905109. doi: 10.3389/fimmu.2022.905109. eCollection 2022.
8
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.2021 年欧洲风湿病学会联盟/美国风湿病学会关于自身炎症性 I 型干扰素病的诊断和治疗的考虑要点:CANDLE/PRAAS、SAVI 和 AGS。
Ann Rheum Dis. 2022 May;81(5):601-613. doi: 10.1136/annrheumdis-2021-221814. Epub 2022 Jan 27.
9
Spectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies.与单基因干扰素病相关的神经放射学表现谱。
AJNR Am J Neuroradiol. 2022 Jan;43(1):2-10. doi: 10.3174/ajnr.A7362. Epub 2021 Dec 23.
10
STING-Mediated Lung Inflammation and Beyond.STING 介导的肺部炎症及其他作用
J Clin Immunol. 2021 Apr;41(3):501-514. doi: 10.1007/s10875-021-00974-z. Epub 2021 Feb 2.
疾病相关突变鉴定出人 STING 中控制 I 型干扰素信号所必需的一个新区域。
J Allergy Clin Immunol. 2017 Aug;140(2):543-552.e5. doi: 10.1016/j.jaci.2016.10.031. Epub 2017 Jan 10.
4
Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173.托法替布可缓解由TMEM173基因的2个新发变异导致的婴儿期起病的干扰素基因刺激物(STING)相关血管病的症状。
J Allergy Clin Immunol. 2017 Apr;139(4):1396-1399.e12. doi: 10.1016/j.jaci.2016.10.030. Epub 2016 Dec 29.
5
Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation).严重肺纤维化作为干扰素病(TMEM173 突变)的首发表现。
Chest. 2016 Sep;150(3):e65-71. doi: 10.1016/j.chest.2016.02.682.
6
Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy.婴儿期起病的与干扰素基因刺激蛋白(STING)相关血管病所致间质性肺疾病
Am J Respir Crit Care Med. 2016 Sep 1;194(5):639-42. doi: 10.1164/rccm.201510-2102LE.
7
Familial chilblain lupus due to a gain-of-function mutation in STING.家族性冻疮样狼疮继发于 STING 基因功能获得性突变。
Ann Rheum Dis. 2017 Feb;76(2):468-472. doi: 10.1136/annrheumdis-2016-209841. Epub 2016 Aug 26.
8
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.Janus激酶1/2抑制剂芦可替尼治疗3例与TMEM173激活突变相关的血管病变患儿的疗效
J Allergy Clin Immunol. 2016 Dec;138(6):1752-1755. doi: 10.1016/j.jaci.2016.07.015. Epub 2016 Aug 20.
9
Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.靶向TBK1在自身免疫性疾病和干扰素病中的治疗潜力。
Pharmacol Res. 2016 Sep;111:336-342. doi: 10.1016/j.phrs.2016.04.008. Epub 2016 Jun 25.
10
Type I interferonopathies in pediatric rheumatology.儿童风湿病中的I型干扰素病
Pediatr Rheumatol Online J. 2016 Jun 4;14(1):35. doi: 10.1186/s12969-016-0094-4.